The role of spinal nuclear factor-kappa B in spinal hyperexcitability

NeuroReport

Volumn 17, Issue 15, 2006, Pages 1615-1618

  Ebersberger, Andrea ^a   Buchmann, Melanie ^a   Ritzeler, Olaf ^b   Michaelis, Martin ^b   Schaible, Hans Georg ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b SANOFI AVENTIS DEUTSCHLAND GMBH   (Germany)

Author keywords

Central sensitization; I B kinase inhibitor; Inflammation; Nuclear factor B

Indexed keywords

I KAPPA B KINASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; S 1627; UNCLASSIFIED DRUG;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; EXCITABILITY; HEART FUNCTION TEST; KNEE ARTHRITIS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; SPINAL CORD DORSAL HORN; SPINAL HYPEXCITABILITY; SPINE; SPINE DISEASE;

ANIMALS; ARTHRITIS, EXPERIMENTAL; ENZYME INHIBITORS; MALE; NF-KAPPA B; POSTERIOR HORN CELLS; RATS; RATS, WISTAR; SPINAL CORD; TIME FACTORS;

EID: 33749013824     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.wnr.0000236867.76347.60     Document Type: Article

References (10)

1. Barnes PJ, Karin M. Nuclear factor-κB: a pivotal transcription factor in chronic inflammatory diseases. New Engl J Med 1997; 336:1066-1071.
2. Chen L-W, Egan L, Li Z-W, Greten FR, Kagnoff MF, Karin M. The two faces of IKK and NF-κB inhibition: prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion. Nat Med 2003; 9:575-581.
3. Tegeder I, Niederberger E, Schmidt R, Kunz S, Gühring H, Ritzeler O, et al. Specific inhibition of IκB kinase reduces hyperalgesia in inflammatory and neuropathic pain models in rats. J Neurosci 2004; 24:1637-1645.
4. Lee KM, Kang BS, Lee HL, Son SJ, Hwang SH, Kim DS, et al. Spinal NF-κB activation induces COX-2 upregulation and contributes to inflammatory pain hypersensitivity. Eur J Neurosci 2004; 19:3375-3381.
5. Woolf CJ, Salter MW. Neuronal plasticity: increasing the gain in pain. Science 2000; 288:1765-1768.
6. Ebersberger A, Buchmann M, Michaelis M, Schaible H-G. Topical application of an IkappaB inhibitor prevents the development of inflammation-induced hyperexcitability of spinal cord neurons. Pflügers Arch 2004; 447:S113.
7. Schaible H-G. Basic mechanisms of deep somatic pain. In: McMahon SB, Koltzenburg M, editors. Textbook of pain. 5th ed. Amsterdam: Elsevier; 2005. pp.621-633.
8. Vasquez E, Bär K-J, Ebersberger A, Klein B, Vanegas H, Schaible H-G. Spinal prostaglandins are involved in the development but not the maintenance of inflammation-induced spinal hyperexcitability. J Neurosci 2001; 21:9001-9008.
9. Vanegas H, Schaible H-G. Prostaglandins and cyclooxygenases in the spinal cord. Prog Neurobiol 2001; 64:327-363.
10. Telleria-Diaz A, Neubert A-K, Schache F, Vasquez E, Ebersberger A, Vanegas H, et al. Different effects of spinally applied COX-1, COX-2 and non-selective COX inhibitors on inflammation-evoked spinal hyperexcitability. In: Flor H, Kalso E, Dostrovsky JO, editors. Proceedings of the 11th World Congress on Pain. Seattle: IASP Press; 2006.